Calcitonin Gene-related Peptide Receptor Antagonist
8 drugs across 3 manufacturers|0 Generic,8 Brand
The Calcitonin Gene-related Peptide Receptor Antagonist class contains 8 NDCs from 3 manufacturers (0 generic, 8 brand), at an average NADAC of $95.18 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
8
0G / 8B
Manufacturers
3
Avg $95.1755/unit
Avg 7d Change
-0.06%
Across 7 drugs with changes
7d Activity
of 8 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Frequently Asked Questions
How many drugs are in the Calcitonin Gene-related Peptide Receptor Antagonist class?
The Calcitonin Gene-related Peptide Receptor Antagonist class contains 8 NDCs from 3 manufacturers — 0 generic and 8 brand products.
What is the average price of Calcitonin Gene-related Peptide Receptor Antagonist drugs?
The average NADAC for the Calcitonin Gene-related Peptide Receptor Antagonist class is $95.1755 per unit across 8 NDCs.
Which manufacturers make Calcitonin Gene-related Peptide Receptor Antagonist drugs?
3 manufacturers make drugs in the Calcitonin Gene-related Peptide Receptor Antagonist class. Ranked by number of NDCs, the largest are Allergan, Inc. (3), AbbVie Inc. (3), Pfizer Inc. (2).
How has Calcitonin Gene-related Peptide Receptor Antagonist pricing changed recently?
Over the past 7 days, 4 NDCs in this class rose and 3 fell, with a class-wide average change of -0.1%.
Manufacturer Breakdown
3 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ZAVZPRET 10 MG NASAL SPRAY zavegepant | $190.1278 per EA | -0.04% |
NURTEC ODT 75 MG TABLET rimegepant sulfate | $128.7114 per EA | +0.01% |
UBRELVY 100 MG TABLET ubrogepant | $109.1802 per EA | +0.01% |
UBRELVY 100 MG TABLET ubrogepant | $109.1802 per EA | +0.01% |
UBRELVY 50 MG TABLET ubrogepant | $108.9663 per EA | 0.00% |
QULIPTA 60 MG TABLET Atogepant | $38.4725 per EA | +0.02% |
QULIPTA 30 MG TABLET Atogepant | $38.4051 per EA | -0.16% |
QULIPTA 10 MG TABLET Atogepant | $38.3609 per EA | -0.13% |